Inhibition of Protein Kinases by Balanol: Specificity Within the Serine/threonine Protein Kinase Subfamily
Overview
Pharmacology
Affiliations
Balanol is a potent inhibitor of cyclic AMP-dependent protein kinase and protein kinase C, acting competitively with ATP with an affinity 3000 times that of ATP. We tested the capacity of balanol to inhibit representative serine- and threonine-specific protein kinases from the protein kinase subfamily that shares a common conserved catalytic core with cyclic AMP-dependent protein kinase. Balanol's pattern of interactions indicates considerable diversity of the ATP/balanol-binding sites of protein kinases within familial groups and even among isoforms of the same kinase. We propose that balanol is a protean structure that may be modified to produce selective, high-affinity inhibitors and probes of the ATP-binding sites of serine/threonine protein kinases.
Compounds from Natural Sources as Protein Kinase Inhibitors.
Baier A, Szyszka R Biomolecules. 2020; 10(11).
PMID: 33198400 PMC: 7698043. DOI: 10.3390/biom10111546.
Mangmool S, Parichatikanond W, Kurose H Front Pharmacol. 2018; 9:1336.
PMID: 30538631 PMC: 6277550. DOI: 10.3389/fphar.2018.01336.
Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.
Qin L, Sankaran B, Aminzai S, Casteel D, Kim C J Biol Chem. 2018; 293(28):10985-10992.
PMID: 29769318 PMC: 6052212. DOI: 10.1074/jbc.RA118.002427.
Waldschmidt H, Homan K, Cruz-Rodriguez O, Cato M, Waninger-Saroni J, Larimore K J Med Chem. 2016; 59(8):3793-807.
PMID: 27050625 PMC: 4890168. DOI: 10.1021/acs.jmedchem.5b02000.
The essential roles of chemistry in high-throughput screening triage.
Dahlin J, Walters M Future Med Chem. 2014; 6(11):1265-90.
PMID: 25163000 PMC: 4465542. DOI: 10.4155/fmc.14.60.